BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29701680)

  • 1.
    Li G; Mei S; Cheng J; Wu T; Luo J
    Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Vaccinia Virus Expressing
    Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li G; Cheng J; Mei S; Wu T; Ye T
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
    Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
    Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Vaccinia Virus Carrying
    Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
    Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncolytic Vaccinia Virus Harboring
    Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
    Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus carrying gene encoding Haliotis discus discus sialic acid binding lectin induces cancer cell apoptosis.
    Yang X; Wu L; Duan X; Cui L; Luo J; Li G
    Mar Drugs; 2014 Jun; 12(7):3994-4004. PubMed ID: 24983642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell Survival.
    Wu B; Mei S; Cui L; Zhao Z; Chen J; Wu T; Li G
    Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28335432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
    Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
    Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Vaccinia Virus Harboring
    Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
    Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor effects of immune cell-viral biotherapy.
    Thorne SH; Negrin RS; Contag CH
    Science; 2006 Mar; 311(5768):1780-4. PubMed ID: 16556847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
    Breitbach CJ; Arulanandam R; De Silva N; Thorne SH; Patt R; Daneshmand M; Moon A; Ilkow C; Burke J; Hwang TH; Heo J; Cho M; Chen H; Angarita FA; Addison C; McCart JA; Bell JC; Kirn DH
    Cancer Res; 2013 Feb; 73(4):1265-75. PubMed ID: 23393196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
    Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.